First new asthma attack treatment in 50 years
bbc.com
bbc.com
The issue with this class of meds is that they are unfortunately prohibitly expensive. 400€ for a single shot, and you may need up to to 6 per month, for the rest of your life. The new one likely won't be cheaper, all the -mab are that expensive. In large part because they are also very difficult to produce (you need to cultivate cells that produce these antibodies) so it's difficult for competition to enter the field.
Might be more clear to say -mab indicates _monoclonal_ antibodies, _engineered_ for specific purposes, in this case such as interfering with an over-amplified immune response.
So while it’s not surprising that a new flavor in a class of drugs is also expensive, it’s not a foregone conclusion. A new catalyst or a less tricky bond to force could make a drug that works as well or almost but is much cheaper to make.
Magnesium (200mg) and Iodine (1mg). After several months on just that: "Your lungs are better than average for your age".
Your mileage may vary. I doubt there is one size fits all solution, but this has served me well for years.
I started with kelp tablets for the iodine 150mcg x6. But not I just use Lugols solution in my morning caffeine drink.
1mg == 1000 micrograms. RDA for iodine is about 150mcg for teens and adults, 220mcg for pregnant women and 290mcg for lactating women. I think the Japanese diets contain 1000-3000mcg (1-3mg).
I take 400-600mcg of iodine every other day. This is 2-3 drops in water. The carrier is ethanol. Pure iodine doesn't dissolve in water, so the drops become a cloud when dispensed into water.
Is anyone better versed on the causes, though? Prevention is better than cure after all- and much better than just treatment.
I’m curious if something in our environment is causing this, because you would presume that natural selection would have run its course on us, as without treatment I would certainly not have made it into adulthood.
Western populations are overweight and sedentary.
Correlation isn't causation but seems like that has to be a major factor.
I am very frustrated that the research on calcilytics, which look so promising, appear hopelessly and inexplicably stalled. People in academia won't even answer my emails asking why clinical trials aren't proceeding.
If the drug shows promising results it should be available with an added disclosure.
You can buy cancer causing cigarettes over the counter but not a drug that has already shown results.
It’s frustrating
It’s a weak line of reasoning to _allow_ cigarettes, but I’m not convinced it’s so bad to _disallow_ novel therapeutic uses that are understudied.